201 related articles for article (PubMed ID: 24187404)
1. Primary ovarian insufficiency in children after treatment with 131I-metaiodobenzylguanidine for neuroblastoma: report of the first two cases.
Clement SC; Kraal KC; van Eck-Smit BL; van den Bos C; Kremer LC; Tytgat GA; van Santen HM
J Clin Endocrinol Metab; 2014 Jan; 99(1):E112-6. PubMed ID: 24187404
[TBL] [Abstract][Full Text] [Related]
2. Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases.
van Santen HM; Tytgat GA; van de Wetering MD; van Eck-Smit BL; Hopman SM; van der Steeg AF; Nieveen van Dijkum EJ; van Trotsenburg AS
Thyroid; 2012 Jun; 22(6):643-6. PubMed ID: 22524499
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance.
Clement SC; van Eck-Smit BL; van Trotsenburg AS; Kremer LC; Tytgat GA; van Santen HM
Pediatr Blood Cancer; 2013 Nov; 60(11):1833-8. PubMed ID: 23832530
[TBL] [Abstract][Full Text] [Related]
4. 131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients.
Garaventa A; Bellagamba O; Lo Piccolo MS; Milanaccio C; Lanino E; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Claudiani F; De Bernardi B
Br J Cancer; 1999 Dec; 81(8):1378-84. PubMed ID: 10604736
[TBL] [Abstract][Full Text] [Related]
5. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
[TBL] [Abstract][Full Text] [Related]
6. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
7. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
[TBL] [Abstract][Full Text] [Related]
9. The role of 131I-MIBG in high-risk neuroblastoma treatment.
Lessig MK
J Pediatr Oncol Nurs; 2009; 26(4):208-16. PubMed ID: 19726792
[TBL] [Abstract][Full Text] [Related]
10. Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients.
Klingebiel T; Feine U; Treuner J; Reuland P; Handgretinger R; Niethammer D
J Nucl Biol Med (1991); 1991; 35(4):216-9. PubMed ID: 1823821
[TBL] [Abstract][Full Text] [Related]
11. Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma.
van Santen HM; de Kraker J; van Eck BL; de Vijlder JJ; Vulsma T
Cancer; 2003 Jul; 98(2):389-96. PubMed ID: 12872361
[TBL] [Abstract][Full Text] [Related]
12. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapy with low doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma.
Weyl Ben-Arush M; Ben Barak A; Bar-Deroma R; Ash S; Goldstein G; Golan H; Houri H; Waldman D; Nevo N; Bar Shalom R; Berniger A; Nevelsky A; Toren A; Yaniv I; Kuten A
Isr Med Assoc J; 2013 Jan; 15(1):31-4. PubMed ID: 23484236
[TBL] [Abstract][Full Text] [Related]
14. [131I]MIBG as a first line treatment in advanced neuroblastoma.
Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
[TBL] [Abstract][Full Text] [Related]
15. [131I]metaiodobenzylguanidine in neuroblastoma patients at diagnosis.
Mastrangelo R; Lasorella A; Troncone L; Rufini V; Iavarone A; Riccardi R
J Nucl Biol Med (1991); 1991; 35(4):252-4. PubMed ID: 1823829
[TBL] [Abstract][Full Text] [Related]
16. Outcome of [131I]metaiodobenzylguanidine therapy of neuroblastoma: seven years after.
Hör G; Maul FD; Kornhuber B; Schwabe D; Hesse J; Manegold KH; Baüm RP; Gerein V
J Nucl Biol Med (1991); 1991; 35(4):207-15. PubMed ID: 1823820
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma.
Johnson K; McGlynn B; Saggio J; Baniewicz D; Zhuang H; Maris JM; Mosse YP
Pediatr Blood Cancer; 2011 Dec; 57(7):1124-9. PubMed ID: 21495159
[TBL] [Abstract][Full Text] [Related]
18. Endocrine late effects from multi-modality treatment of neuroblastoma.
van Santen HM; de Kraker J; Vulsma T
Eur J Cancer; 2005 Aug; 41(12):1767-74. PubMed ID: 16039114
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.
Matthay KK; Huberty JP; Hattner RS; Ablin AR; Engelstad BL; Zoger S; Hasegawa BH; Price D
J Nucl Biol Med (1991); 1991; 35(4):244-7. PubMed ID: 1823827
[TBL] [Abstract][Full Text] [Related]
20. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
